EW vs WLYB · P/E 47, rev $3.39B vs P/E 15, $2.26B cap
Edwards Lifesciences Corp (EW) versus John Wiley & Sons B (WLYB) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
John Wiley & Sons B (WLYB) is a publishing company listed on NYSE.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
WLYB does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. WLYB currently screens at market cap $2.26B and trailing P/E 15.4.
Not investment advice. Open the EW and WLYB stock pages for the full models.
Not investment advice.